Back
Insurance Payer Status and Race Explains Much of the Variability in Colorectal Cancer Survival
Timothy L. Fitzgerald, Cary Suzanne Lea, Prashanti M. Atluri, Jason Brinkley, Emmanuel E. Zervos
J. Cancer Ther. Vol.5 No.13, November 11, 2014  DOI: 10.4236/jct.2014.513124
       (PDF  3033K)     HTML      XML
Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Colorectal Cancer after Failure of Second-Line Therapy—A Potential Strategy for Improved Survival
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Sheldon Brookman
J. Cancer Ther. Vol.5 No.13, November 20, 2014  DOI: 10.4236/jct.2014.513128
       (PDF  3899K)     HTML      XML
Effects of Surgery and Palliative Chemotherapy in the Treatment of Colorectal Liver Metastasis
Nigel Bird, Ruth Bird, Ali Majeed
Surg. Sci. Vol.2 No.6, August 16, 2011  DOI: 10.4236/ss.2011.26066
       (PDF  219K)     HTML     
Carcinoembryonic Antigen as a Prognostic Factor in Colorectal Cancer with Liver Metastases
George E. McNally, David M. Lloyd, Jorge P. Grondona
J. Cancer Ther. Vol.6 No.12, November 05, 2015  DOI: 10.4236/jct.2015.612113
       (PDF  932K)     HTML      XML
Clinical applications of molecular profiling in colorectal cancer: Review of the literature
Elrasheid A. H. Kheirelseid, Nicola Miller, Michael J. Kerin
Am. J. Mol. Biol. Vol.3 No.2, April 30, 2013  DOI: 10.4236/ajmb.2013.32017
       (PDF  85K)     HTML      XML
 
 
Top